Medical care of kidney transplant recipients after the first posttransplant

被引:72
作者
Djamali, Arjang
Samaniego, Millie
Muth, Brenda
Muehrer, Rebecca
Hofmann, R. Michael
Pirsch, John
Howard, Andrew
Mourad, Georges
Becker, Bryan N.
机构
[1] Univ Wisconsin, Nephrol Sect, Dept Med, Madison, WI USA
[2] Metropolitan Nephrol Assoc, Alexandria, VA USA
[3] Montpellier Med Sch, Montpellier, France
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 1卷 / 04期
关键词
D O I
10.2215/CJN.01371005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Kidney transplantation is the treatment of choice for patients with ESRD. Despite improvements in short-term patient and graft outcomes, there has been no major improvement in long-term outcomes. The use of kidney allografts from expanded-criteria donors, polyoma virus nephropathy, underimmunosuppression, and incomplete functional recovery after rejection episodes may play a role in the lack of improvement in long-term outcomes. Other factors, including cardiovascular disease, infections, and malignancies, also shorten patient survival and therefore reduce the functional life of an allograft. There is a need for interventions that improve long-term outcomes in kidney transplant recipients. These patients are a unique subset of patients with chronic kidney disease. Therefore, interventions need to address disease progression, comorbid conditions, and patient mortality through a multifaceted approach. The Kidney Disease Outcomes Quality Initiative from the National Kidney Foundation, the European Best Practice Guidelines, and the forthcoming Kidney Disease: Improving Global Outcomes clinical practice guidelines can serve as a cornerstone of this approach. The unique aspects of chronic kidney disease in the transplant recipient require the integration of specific transplant-oriented problems into this care schema and a concrete partnership among transplant centers, community nephrologists, and primary care physicians. This article reviews the contemporary aspects of care for these patients.
引用
收藏
页码:623 / 640
页数:18
相关论文
共 198 条
[1]   Late urinary tract infection after renal transplantation in the United States [J].
Abbott, KC ;
Swanson, SJ ;
Richter, ER ;
Bohen, EM ;
Agodoa, LY ;
Peters, TG ;
Barbour, G ;
Lipnick, R ;
Cruess, DF .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (02) :353-362
[2]  
ABTAHI P, 2001, GRAFT, V4, P266
[3]   Gastric bypass in morbidly obese patients with chronic renal failure and kidney transplant [J].
Alexander, JW ;
Goodman, HR ;
Gersin, K ;
Cardi, M ;
Austin, J ;
Goel, S ;
Safdar, S ;
Huang, SM ;
Woodle, ES .
TRANSPLANTATION, 2004, 78 (03) :469-474
[4]  
[Anonymous], 2001, Am J Kidney Dis, V37, pS182
[5]  
[Anonymous], 2002, NEPHROL DIAL TRAN S4, V17, p43e48
[6]  
[Anonymous], 2003, American Medical Journal of Kidney Disease, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3
[7]  
[Anonymous], 2004, AM J TRANSPLANT S7, V4, pS7
[8]   Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients [J].
Armstrong, KA ;
Campbell, SB ;
Hawley, CM ;
Nicol, DL ;
Johnson, DW ;
Isbel, NM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (11) :2710-2718
[9]   Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy [J].
Artz, MA ;
Hilbrands, LB ;
Borm, G ;
Assmann, KJM ;
Wetzels, JFM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (11) :2852-2857
[10]   Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients [J].
Augustine, JJ ;
Knauss, TC ;
Schulak, JA ;
Bodziak, KA ;
Siegel, C ;
Hirick, DE .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (12) :2001-2006